Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kylie M Konrath

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cancer Chemotherapy and Pharmacology|March 19, 2020
Metabolism and pharmacokinetics characterization of metarrestin in multiple speciesElias C Padilha, Pranav Shah, Amy Q Wang, et al.
ACS Chemical Neuroscience|February 3, 2022
Hydroxynorketamine Pharmacokinetics and Antidepressant Behavioral Effects of (2<i>,</i>6)- and (5<i>R</i>)-Methyl-(2<i>R,</i>6<i>R</i>)-hydroxynorketaminesJaclyn N Highland, Patrick J Morris, Kylie M Konrath, et al.
Frontiers in Immunology|February 17, 2025
Structural engineering of stabilized, expanded epitope nanoparticle vaccines for HPVMichaela Helble, Xizhou Zhu, Pratik S Bhojnagarwala, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2025
Machine learning enables <i>de novo</i> multi-epitope design of plasmodium falciparum circumsporozoite protein to target trimeric L9 antibodyJ Andrew D Nelson, Samuel E Garfinkle, Zi Jie Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2025
Machine learning enables de novo multiepitope design of <i>Plasmodium falciparum</i> circumsporozoite protein to target trimeric L9 antibodyJ Andrew D Nelson, Samuel E Garfinkle, Zi Jie Lin, et al.
Vaccine|May 21, 2025
DNA co-delivery of seasonal H1 influenza hemagglutinin nanoparticle vaccines with chemokine adjuvant CTACK induces potent immunogenicity for heterologous protection in vivoKevin Liaw, Kylie M Konrath, Abigail R Trachtman, et al.
Nature Communications|February 5, 2022
Induction of tier-2 neutralizing antibodies in mice with a DNA-encoded HIV envelope native like trimerZiyang Xu, Susanne Walker, Megan C Wise, et al.
Cell Reports|January 29, 2022
Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drives rapid and potent immunogenicity capable of single-dose protectionKylie M Konrath, Kevin Liaw, Yuanhan Wu, et al.
Plos Pathogens|February 19, 2026
Immune-focused RBD nanoparticles induce cross-reactive, RBS-directed responses capable of variant-resistant SARS-CoV-2 neutralizationKylie M Konrath, Kevin Liaw, Nicholas J Tursi, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 8, 2026
mRNA delivery of a class 1/4 SARS-CoV-2 neutralizing antibody protects against diverse sarbecoviruses in a lethal mouse challenge modelAshwin N Skelly, Chengcheng Fan, Jennifer R Keeffe, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cancer Chemotherapy and Pharmacology|March 19, 2020
Metabolism and pharmacokinetics characterization of metarrestin in multiple speciesElias C Padilha, Pranav Shah, Amy Q Wang, et al.
ACS Chemical Neuroscience|February 3, 2022
Hydroxynorketamine Pharmacokinetics and Antidepressant Behavioral Effects of (2<i>,</i>6)- and (5<i>R</i>)-Methyl-(2<i>R,</i>6<i>R</i>)-hydroxynorketaminesJaclyn N Highland, Patrick J Morris, Kylie M Konrath, et al.
Frontiers in Immunology|February 17, 2025
Structural engineering of stabilized, expanded epitope nanoparticle vaccines for HPVMichaela Helble, Xizhou Zhu, Pratik S Bhojnagarwala, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2025
Machine learning enables <i>de novo</i> multi-epitope design of plasmodium falciparum circumsporozoite protein to target trimeric L9 antibodyJ Andrew D Nelson, Samuel E Garfinkle, Zi Jie Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2025
Machine learning enables de novo multiepitope design of <i>Plasmodium falciparum</i> circumsporozoite protein to target trimeric L9 antibodyJ Andrew D Nelson, Samuel E Garfinkle, Zi Jie Lin, et al.
Vaccine|May 21, 2025
DNA co-delivery of seasonal H1 influenza hemagglutinin nanoparticle vaccines with chemokine adjuvant CTACK induces potent immunogenicity for heterologous protection in vivoKevin Liaw, Kylie M Konrath, Abigail R Trachtman, et al.
Nature Communications|February 5, 2022
Induction of tier-2 neutralizing antibodies in mice with a DNA-encoded HIV envelope native like trimerZiyang Xu, Susanne Walker, Megan C Wise, et al.
Cell Reports|January 29, 2022
Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drives rapid and potent immunogenicity capable of single-dose protectionKylie M Konrath, Kevin Liaw, Yuanhan Wu, et al.
Plos Pathogens|February 19, 2026
Immune-focused RBD nanoparticles induce cross-reactive, RBS-directed responses capable of variant-resistant SARS-CoV-2 neutralizationKylie M Konrath, Kevin Liaw, Nicholas J Tursi, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 8, 2026
mRNA delivery of a class 1/4 SARS-CoV-2 neutralizing antibody protects against diverse sarbecoviruses in a lethal mouse challenge modelAshwin N Skelly, Chengcheng Fan, Jennifer R Keeffe, et al.
Pageof 1